Noninvasive genetic immunization, expression products therefrom, and uses thereof
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/70
A61K-048/00
C12N-015/00
C12N-005/00
출원번호
US-0533149
(2000-03-23)
발명자
/ 주소
Tang, De-chu C.
Marks, Donald H.
Curiel, David T.
Shi, Zhongkai
출원인 / 주소
The UAB Research Foundation
대리인 / 주소
Frommer Lawrence & Haug, LLP
인용정보
피인용 횟수 :
20인용 특허 :
95
초록▼
Disclosed and claimed are methods of non-invasive genetic immunization in an animal and/or methods of inducing a systemic immune or therapeutic response in an animal, products therefrom and uses for the methods and products therefrom. The methods can include contacting skin of the animal with a vect
Disclosed and claimed are methods of non-invasive genetic immunization in an animal and/or methods of inducing a systemic immune or therapeutic response in an animal, products therefrom and uses for the methods and products therefrom. The methods can include contacting skin of the animal with a vector in an amount effective to induce the systemic immune or therapeutic response in the animal. The vector can include and express an exogenous nucleic acid molecule encoding an epitope or gene product of interest. The systemic immune response can be to or from the epitope or gene product. The nucleic acid molecule can encode an epitope of interest and/or an antigen of interest and/or a nucleic acid molecule that stimulates and/or modulates an immunological response and/or stimulates and/or modulates expression, e.g., transcription and/or translation, such as transcription and/or translation of an endogenous and/or exogenous nucleic acid molecule; e.g., one or more of influenza hemagglutinin, influenza nuclear protein, influenza M2, tetanus toxin C-fragment, anthrax protective antigen, anthrax lethal factor, rabies glycoprotein, HBV surface antigen, HIV gp 120, HIV gp 160, human carcinoembryonic antigen, malaria CSP, malaria SSP, malaria MSP, malaria pfg, and mycobacterium tuberculosis HSP; and/or a therapeutic, an immunomodulatory gene, such as co-stimulatory gene and/or a cytokine gene. The immune response can be induced by the vector expressing the nucleic acid molecule in the animal's cells. The animal's cells can be epidermal cells. The immune response can be against a pathogen or a neoplasm. A prophylactic vaccine or a therapeutic vaccine or an immunological composition can include the vector. The animal can be a vertebrate, e.g., a mammal, such as human, a cow, a horse, a dog, a cat, a goat, a sheep or a pig; or fowl such as turkey, chicken or duck. The vector can be one or more of a viral vector, including viral coat, e.g., with some or all viral genes deleted therefrom, bacterial, protozoan, transposon, retrotransposon, and DNA vector, e.g., a recombinant vector; for instance, an adenovirus, such as an adenovirus defective in its E1 and/or E3 and/or E4 region(s). The method can encompass applying a delivery device including the vector to the skin of the animal, as well as such a method further including disposing the vector in and/or on the delivery device. The vector can have all viral genes deleted therefrom. The vector can induce a therapeutic and/or an anti-tumor effect in the animal, e.g., by expressing an oncogene, a tumor-suppressor gene, or a tumor-associated gene. Immunological products generated by the expression, e.g., antibodies, cells from the methods, and the expression products, are likewise useful in in vitro and ex vivo applications, and such immunological and expression products and cells and applications are disclosed and claimed. Methods for expressing a gene product in vivo and products therefor and therefrom including mucosal and/or intranasal administration of an adenovirus, advantageously an E1 and/or E3 and/or E4 defective or deleted adenovirus, such as a human adenovirus or canine adenovirus, are also disclosed and claimed.
대표청구항▼
Disclosed and claimed are methods of non-invasive genetic immunization in an animal and/or methods of inducing a systemic immune or therapeutic response in an animal, products therefrom and uses for the methods and products therefrom. The methods can include contacting skin of the animal with a vect
Disclosed and claimed are methods of non-invasive genetic immunization in an animal and/or methods of inducing a systemic immune or therapeutic response in an animal, products therefrom and uses for the methods and products therefrom. The methods can include contacting skin of the animal with a vector in an amount effective to induce the systemic immune or therapeutic response in the animal. The vector can include and express an exogenous nucleic acid molecule encoding an epitope or gene product of interest. The systemic immune response can be to or from the epitope or gene product. The nucleic acid molecule can encode an epitope of interest and/or an antigen of interest and/or a nucleic acid molecule that stimulates and/or modulates an immunological response and/or stimulates and/or modulates expression, e.g., transcription and/or translation, such as transcription and/or translation of an endogenous and/or exogenous nucleic acid molecule; e.g., one or more of influenza hemagglutinin, influenza nuclear protein, influenza M2, tetanus toxin C-fragment, anthrax protective antigen, anthrax lethal factor, rabies glycoprotein, HBV surface antigen, HIV gp 120, HIV gp 160, human carcinoembryonic antigen, malaria CSP, malaria SSP, malaria MSP, malaria pfg, and mycobacterium tuberculosis HSP; and/or a therapeutic, an immunomodulatory gene, such as co-stimulatory gene and/or a cytokine gene. The immune response can be induced by the vector expressing the nucleic acid molecule in the animal's cells. The animal's cells can be epidermal cells. The immune response can be against a pathogen or a neoplasm. A prophylactic vaccine or a therapeutic vaccine or an immunological composition can include the vector. The animal can be a vertebrate, e.g., a mammal, such as human, a cow, a horse, a dog, a cat, a goat, a sheep or a pig; or fowl such as turkey, chicken or duck. The vector can be one or more of a viral vector, including viral coat, e.g., with some or all viral genes deleted therefrom, bacterial, protozoan, transposon, retrotransposon, and DNA vector, e.g., a recombinant vector; for instance, an adenovirus, such as an adenovirus defective in its E1 and/or E3 and/or E4 region(s). The method can encompass applying a delivery device including the vector to the skin of the animal, as well as such a method further including disposing the vector in and/or on the delivery device. The vector can have all viral genes deleted therefrom. The vector can induce a therapeutic and/or an anti-tumor effect in the animal, e.g., by expressing an oncogene, a tumor-suppressor gene, or a tumor-associated gene. Immunological products generated by the expression, e.g., antibodies, cells from the methods, and the expression products, are likewise useful in in vitro and ex vivo applications, and such immunological and expression products and cells and applications are disclosed and claimed. Methods for expressing a gene product in vivo and products therefor and therefrom including mucosal and/or intranasal administration of an adenovirus, advantageously an E1 and/or E3 and/or E4 defective or deleted adenovirus, such as a human adenovirus or canine adenovirus, are also disclosed and claimed.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (95)
Muzyczka Nicholas (Stony Brook NY) Hermonat Paul L. (Bethesda MD) Berns Kenneth I. (Mamaroneck NY) Samulski Richard J. (Princeton NJ), AAV transduction vectors.
Gregory Richard J. ; Armentano Donna ; Couture Larry A. ; Smith Alan E., Adenoviral vectors for gene therapy containing deletions in the adenoviral genome.
Gregory Richard J. (Carlsbad CA) Armentano Donna (Watertown MA) Couture Larry A. (Framingham MA) Smith Alan E. (Wellesley MA), Adenovirus vector for gene therapy.
Wickham Thomas J. ; Falck-Pedersen Erik ; Roelvink Petrus W. ; Bruder Joseph T. ; Gall Jason ; Kovesdi Imre, Chimeric adenoviral fiber protein and methods of using same.
Curiel David T. (Chapel Hill NC) Birnstiel Max L. (Vienna ATX) Cotten Matthew (Vienna ATX) Wagner Ernst (Langenzersdorf ATX) Zatloukal Kurt (Vienna ATX) Plank Christian (Vienna ATX) Oberhauser Berndt, Composition for introducing nucleic acid complexes into higher eucaryotic cells.
Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Delivery of exogenous DNA sequences in a mammal.
Wolff Jon A. (Madison WI) Duke David J. (Salem OR) Felgner Philip L. (Rancho Santa Fe CA), Expression of exogenous polynucleotide sequences cardiac muscle of a mammal.
Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon Asher (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert Wallace (Davis CA) Carson Dennis A. (Del Mar CA), Generation of antibodies through lipid mediated DNA delivery.
Felgner Philip L. (Rancho Santa Fe CA) Wolff Jon A. (Madison WI) Rhodes Gary H. (Leucadia CA) Malone Robert W. (Chicago IL) Carson Dennis A. (Del Mar CA), Induction of a protective immune response in a mammal by injecting a DNA sequence.
Zygraich Nathan (Brussels BE) Huygelen Constant (Huldenberg BE), Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them.
Gristina Anthony G. (Reston VA) Myrvik Quentin N. (Caswell Beach NC), Method and compositions for the direct concentrated delivery of passive immunity.
Smith Gale Eugene ; Volvovitz Franklin ; Wilkinson Bethanie Eident ; Hackett Craig Stanway, Method for producing influenza hemagglutinin multivalent vaccines using baculovirus.
Finer Mitchell H. ; Roberts Margo R. ; Dull Thomas J. ; Zsebo Krisztina M. ; Qin Lu ; Farson Deborah A., Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells.
Papahadjopoulos Demetrios P. (78 Heathwood Williamsville NY 14221) Szoka ; Jr. Francis C. (375 Leroy Ave. Buffalo NY 14214), Method of encapsulating biologically active materials in lipid vesicles.
Papahadjopoulos Demetrios P. (78 Heathwood Williamsville NY 14221) Szoka ; Jr. Francis C. (375 Leroy Ave. Buffalo NY 14214), Method of encapsulating biologically active materials in lipid vesicles.
Szoka ; Jr. Francis C. (76 Summit St. Waltham MA 02154) Papahadjopoulos Demetrios P. (3170 Condit St. Lafayette CA 94549), Method of inserting DNA into living cells.
Gristina Anthony G. (11605 Deer Forest Rd. Reston VA 22094) Myrvik Quentin N. (404 Palmetto Dr. Caswell Beach NC 28465), Methods and compositions for the direct concentrated delivery of passive immunity.
Carson Dennis A. (Del Mar CA) Raz Eyal (San Diego CA), Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleoti.
Carson Dennis A. ; Raz Eyal ; Howell Meredith L., Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptide.
Metzger Jorg (Tubingen DEX) Wiesmuller Karl-Heinz (Tubingen DEX) Jung Gunther (Tubingen DEX), N-acyl-S-(2-hydroxyalkyl) cysteines, their preparation and their use as intermediates for the preparation of synthetic i.
Paoletti Enzo (Delmar NY) Perkus Marion E. (Altamont NY) Taylor Jill (Albany NY) Tartaglia James (Schenectady NY) Norton Elizabeth K. (Latham NY) Riviere Michel (Ecully FRX) de Taisne Charles (Lyons , NYVAC vaccinia virus recombinants comprising heterologous inserts.
Patel Dinesh C. (Murray UT) Chang Yunik (Lakewood NJ), Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols.
Elliot James I. (Ottawa CAX) Timbers Gordon E. (Nepean CAX) Modler H. Wayne (Kemptville CAX) Allen Robert W. (Carp CAX), Production of purified porcine immunoglobulins.
Mittal Suresh K.,CAX ; Graham Frank L.,CAX ; Prevec Ludvik,CAX ; Babiuk Lorne A.,CAX, Recombinant protein production in bovine adenovirus expression vector system.
Ertl Hildegund C. J. (Villanova PA) Wilson James M. (Gladwyne PA), Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier.
Tibbetts Clark (Nashville TN) Larsen Pamela L. (Cambridge MA) Jones Stephen N. (Nashville TN) McGrane Mary M. (Cleveland Heights OH), Transcriptional control element adapted for regulation of gene expression in animal cells.
Paoletti Enzo ; Perkus Marion E. ; Taylor Jill ; Tartaglia James ; Norton Elizabeth K. ; Riviere Michel,FRX ; de Taisne Charles,FRX ; Limbach Keith J. ; Johnson Gerard P. ; Pincus Steven E. ; Cox Wil, Trova fowl pox virus recombinants comprising heterologous inserts.
Rose John K. (Solana Beach CA) Moss Bernard (Bethesda MD) Yilma Tilahun (Pullman WA) Mackett Michael (Rusholme GB2), Vaccine for vesicular stomatitis virus.
Huang, Chun-Ming; Zhang, JianFeng; Tang, De-Chu, Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.